AKT1 and colorectal carcinoma: Additionally, Zhan et al. represented CAF-derived EVs containing circN4BP2L2 participate in CRC cell stemness and oxaliplatin resistance by escalating eukaryotic translation initiation factor 4A3 (EIF4A3) and triggering PI3K/AKT/mTOR pathway [213].